
ofer sharon
@oferorama
ID: 24572290
15-03-2009 19:36:28
442 Tweet
27 Followers
37 Following

ืืื ื ืืจืืื ืืื ืืืืจ ืื ืืื ืื ืืช ืืืคื ืืืื ืืืื ืืืืื, ืื ื ืืืื. ืืื ืื ืืื. ืืงืกื ืฉื ืืืืืช ืฉืจื, ืืืชืจ ืืืื ืืื ืืืจ. ืืืื ื ืืืงืช ืืงืื ืงืจืืื, ืืืจื, ืฉืื ืืืจ ื ืืืข ืืื. ืืื ืืกืืคืืจ ืฉื ืืืืฉืื ืืืืช. ืืืกืฃ ืฉื ืื ืฉืื ืืืืื ืคืจืกืื ืืืื ืืืื ืืืคืก ืืืืืืช ืฉืฆืจืื. ืืื.




#ISLB24 abstract submission open. Come one, come all. Denver Co, Nov 23-25. International Society of Liquid Biopsy Christian Rolfo



ืืชื ืืืืื ืืืคืฉ. ืกืื ืืืจ ืื ืืขื ืืื ืืฃ ืืื ืืืื ืฉืื ืืขืื ืืฆืืืง ืขืืื. ืืืืื ืฉืื, ืืืจื ืืฉืจืื, ืืขืืจืจ ืงืืก, ืฆืืจืืืจืช ืืืืขื ืืื ืืฉืจืืื ื ืืจืืื ืื ืืื ืฉืื ืืชืคืจื ืก ืืื ื. ืืืืืจ ืืืคืฉ


#WCLC2024 Getting ready for our ES04 session tomorrow on Challenges in Immunotherapy. New are polling questions. Here is my first, on Hyperprogressive Disease, as per Marina Garassino Do you โbelieveโ?



ื ืชื ืืื ืจืืฆื ืืงืจืื ืืื "ืืืืืช ืืชืงืืื"... ืืื ืื ืืฉืื ื ืขื ืื ืงืืื? 101 ืืืืคืื ืฉื ื ืฉืืื ืืืกืกืื ืืื ืืจืืช ืื ื ืชื ืืื ืืืจืคื ืขืกืงืืืช - ืืชืืืช ืชืงืืื. ืืื ืืืืืจ, ืืื ืืืื, ืืื ืืื, ืืชื ืืื ืืืชื ืื ืืฉืืื - ืืืืืจ, ืชืงืืื. ื ืื ืกืืช ืืืขืื ืื - ืืืืืจื ืืืืืื ืืช ืืชืงืืื. ืืืฆืืื ืืืืจื - ืชืงืืื ืืืืจืื ืืื!



ืืื ืชื ืฉืืืจืื. ืืืืขืืจ ืื ืืื, ืงืื ืื ืืืืื. yonatan shamriz | ืืื ืชื ืฉืืจืื

#ISLB2024 Annual Congress. Can't wait to hear Mary's insights at Multidisciplinary Stakeholder Workshop. Check out panelists & questions posed to Panel #1 on clin applications. (Panel 2 -translational sci) International Society of Liquid Biopsy Christian Rolfo Umberto Malapelle ELO M JOSE SERRANO Lab (LB&Cancer Interception group)


Meet Ofer Sharon (ofer sharon) at #ISLB24! Ofer Sharon, MD is the CEO of OncoHost, a precision oncology companyย developing a liquid biopsy test combining AI, system biology, and bioinformatics. Ofer is a physician and serial biotech entrepreneur. Register Now at


Continuing with showcase presentation at #ISLB24 by OncoHost on plasma proteomics in Immunotherapy presenting their pipeline and data. International Society of Liquid Biopsy David Gandara


We have previously described a novel plasma proteomic predictor for immunotherapy of NSCLC. doi.org/10.1200/PO.23.โฆ At AACR 2025 we present the biological rationale and function of these proteins. Potential broad therapeutic implications doi.org/10.1158/1538-7โฆ International Society of Liquid Biopsy
